KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 8.38
-0.11 (-1.30%)
Sep 10, 2026, 11:29 AM CST
KPC Pharmaceuticals,Inc. Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,867 | 6,575 | 8,401 | 8,430 | 8,282 | 8,254 |
Revenue Growth | -38.84% | -21.74% | -0.34% | 1.79% | 0.35% | 6.95% |
Gross Profit Gross Profit Growth | 1,453 | 2,512 | 3,631 | 3,886 | 3,427 | 3,389 |
Operating Income Operating Income Growth | -480.84 | 268.1 | 816.64 | 696.42 | 563.54 | 409.19 |
Net Income Net Income Growth | -212.36 | 349.94 | 648.08 | 540.71 | 383.18 | 507.67 |
Earnings Per Share EPS Growth | -0.28 | 0.46 | 0.86 | 0.71 | 0.51 | 0.67 |
EPS Growth | - | -46.51% | 21.13% | 39.22% | -23.88% | 11.33% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Pharmaceutical Industry Segment Pharmaceutical Industry Segment Growth | 3,735 | 4,870 | 5,431 | 4,904 |
Pharmaceutical Wholesale Division Pharmaceutical Wholesale Division Growth | 3,268 | 3,983 | 3,369 | 3,766 |
Intersegment Elimination Intersegment Elimination Growth | -428.58 | -451.56 | -370.3 | -387.51 |
Total Total Growth | 6,575 | 8,401 | 8,430 | 8,282 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,711 | 2,344 | 2,737 | 2,103 | 1,978 | 1,735 |
Total Debt Total Debt Growth | 1,635 | 1,685 | 833.02 | 900.74 | 1,140 | 828 |
Net Cash (Debt) Net Cash Growth | 76.01 | 658.37 | 1,904 | 1,203 | 838.19 | 906.76 |
Net Cash Growth | -94.42% | -65.42% | 58.33% | 43.47% | -7.56% | -9.49% |
Net Cash Per Share Net Cash Per Share Growth | 0.10 | 0.87 | 2.53 | 1.58 | 1.12 | 1.20 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -443.62 | 289.24 | 808.07 | 754.33 | 253.9 | 251.63 |
Capital Expenditures CapEx Growth | -110.48 | -90.56 | -79.43 | -109.64 | -101.75 | -236.17 |
Free Cash Flow Free Cash Flow Growth | -554.1 | 198.68 | 728.63 | 644.69 | 152.15 | 15.46 |
Free Cash Flow Growth | - | -72.73% | 13.02% | 323.72% | 884.44% | -93.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.85% | 38.21% | 43.22% | 46.10% | 41.38% | 41.06% |
Operating Margin | -9.88% | 4.08% | 9.72% | 8.26% | 6.80% | 4.96% |
Pretax Margin | -4.54% | 7.20% | 11.12% | 9.33% | 5.76% | 7.65% |
Profit Margin | -4.36% | 5.32% | 7.71% | 6.41% | 4.63% | 6.15% |
FCF Margin | -11.39% | 3.02% | 8.67% | 7.65% | 1.84% | 0.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.180 | 0.180 | 0.300 | 0.200 | 0.160 | 0.270 |
Dividend Per Share Growth | -40.00% | -40.00% | 50.00% | 25.00% | -40.74% | 17.39% |
Dividend Yield | 2.11% | 1.46% | 1.97% | 1.01% | 1.21% | 2.66% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 27.17 | 18.51 | 29.24 | 27.94 | 16.50 |
Forward PE | 39.80 | 13.01 | 18.24 | 23.08 | 17.54 | 13.16 |
P/FCF Ratio | - | 47.86 | 16.47 | 24.53 | 70.37 | 542.13 |
PS Ratio | 1.32 | 1.45 | 1.43 | 1.88 | 1.29 | 1.01 |